Tarsus Pharmaceuticals (TARS) Cash from Investing Activities (QoQ) (2020 - 2026)
Tarsus Pharmaceuticals (TARS) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Tarsus Pharmaceuticals | 2.58 Bn | 2.48 Bn | 152.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -218.85% |
| Dec 31, 2025 | 1,138.88% |
| Sep 30, 2025 | 90.83% |
| Jun 30, 2025 | -47.97% |
| Mar 31, 2025 | 41.35% |
| Dec 31, 2024 | -2,004.54% |
| Sep 30, 2024 | 107.72% |
| Jun 30, 2024 | 60.36% |
| Mar 31, 2024 | -672.68% |
| Dec 31, 2023 | -62.32% |
| Sep 30, 2023 | -26.09% |
| Jun 30, 2023 | 467.49% |
| Mar 31, 2023 | 112.95% |
| Dec 31, 2022 | -52.68% |
| Sep 30, 2022 | -46,725.41% |
| Jun 30, 2022 | 24.22% |
| Mar 31, 2022 | 41.24% |
| Dec 31, 2021 | -126.45% |
| Sep 30, 2021 | -656.25% |
| Jun 30, 2021 | 90.86% |